Pharmafile Logo

Confidential contracting

- PMLiVE

Merck CEO resigns from Trump post in Charlottesville protest

Frazier leaves the Manufacturing Council but J&J’s Gorksy remains for now

- PMLiVE

Toward an outcome

Disrupting the product-centred development cycle

- PMLiVE

Hacking Innovation

RB’s Lions Health event saw teams compete to protect children in China from air pollution

- PMLiVE

Time running out on new Stada takeover bid

Only 34% of shareholders have backed the deal so far

- PMLiVE

Being social – harnessing the power of social media

With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

Porterhouse Medical Group

- PMLiVE

Ionis must go it alone as GSK ditches polyneuropathy drug

Inotersen’s side effects prompts pharma giant to relinquish rights

- PMLiVE

NICE expands Merck KGaA’s Erbitux reach

Backs the medicines use for patients with SCCHN

- PMLiVE

Righting pharma’s reputational wrongs

Addressing the issues of transparency in pharma

- PMLiVE

Ditch the data?

Looking beyond the data

Celgene building

Celgene steps back from $1bn Sutro acquisition

Instead opts for amended licensing deal with US biotech

- PMLiVE

Biotecnol taps into Cancer Research UK network for first trial

New drug hoped to have broad activity across multiple tumour types

- PMLiVE

Leading Edge bolsters its delivery team

After earlier announcements that Lucid Partners was growing its medical writing team, Leading Edge (a Lucid Group company) proudly announces that it is strengthening its delivery team.Francesca Worthington joined Leading Edge...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links